Table 1.
Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of CSA-13 against different clinical isolates of Staphylococcus aureus
| Bacteria source | Strain number | Strain characteristic | CSA-13 (μmol l−1) | |||
|---|---|---|---|---|---|---|
|
| ||||||
| MRSA | MLSB | β-lactamase | MIC | MBC | ||
| Surgery wound | 1 | + | + | + | 0·8 | 3·125 |
| Surgery wound | 2 | + | + | + | 1·56 | 3·125 |
| Surgery wound | 3 | + | + | + | 0·8 | 3·125 |
| Diabetic foot ulcer | 4 | + | + | + | 0·8 | 1·56 |
| Diabetic foot ulcer | 5 | − | + | + | 0·8 | 3·125 |
| Diabetic foot ulcer | 6 | − | + | + | 1·56 | 3·125 |
| Diabetic foot ulcer | 7 | − | + | + | 1·56 | 6·25 |
| Vaginal swabs | 8 | − | + | + | 1·56 | 6·25 |
| Nasal swab | 9 | − | − | + | 1·56 | 6·25 |
| Pus from acne | 10 | − | − | + | 1·56 | 6·25 |
| Pus from acne | 11 | − | − | + | 0·8 | 3·125 |
| Vaginal swabs | 12 | − | − | + | 0·8 | 3·125 |
| Nasal swab | 13 | − | − | − | 1·56 | 6·25 |
| Pus from acne | 14 | − | − | − | 0·8 | 6·25 |
| Pus from acne | 15 | − | − | − | 0·8 | 6·25 |
| Pus from furunculus | 16 | − | − | − | 3·125 | 6·25 |
| Staph. aureus ATCC29213 | 17 | − | − | + | 0·8 | 3·125 |